2096 Stock Overview
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Simcere Pharmaceutical Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$5.40 |
| 52 Week High | HK$9.58 |
| 52 Week Low | HK$4.94 |
| Beta | 0.46 |
| 1 Month Change | 1.69% |
| 3 Month Change | 2.86% |
| 1 Year Change | -41.30% |
| 3 Year Change | -32.67% |
| 5 Year Change | n/a |
| Change since IPO | -32.75% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2096 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | 3.1% | 2.9% | 2.6% |
| 1Y | -41.3% | -15.1% | -7.4% |
Return vs Industry: 2096 underperformed the Hong Kong Pharmaceuticals industry which returned -15.7% over the past year.
Return vs Market: 2096 underperformed the Hong Kong Market which returned -8.5% over the past year.
Price Volatility
| 2096 volatility | |
|---|---|
| 2096 Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in HK Market | 15.0% |
| 10% least volatile stocks in HK Market | 3.6% |
Stable Share Price: 2096 has not had significant price volatility in the past 3 months.
Volatility Over Time: 2096's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 7,027 | Jinsheng Ren | www.simcere.com |
Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. The company focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN, a simnotrelvir tablets/ritonavir tablets.
Simcere Pharmaceutical Group Limited Fundamentals Summary
| 2096 fundamental statistics | |
|---|---|
| Market cap | HK$13.86b |
| Earnings (TTM) | HK$772.00m |
| Revenue (TTM) | HK$7.14b |
18.0x
P/E Ratio1.9x
P/S RatioIs 2096 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2096 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.61b |
| Cost of Revenue | CN¥1.62b |
| Gross Profit | CN¥4.98b |
| Other Expenses | CN¥4.27b |
| Earnings | CN¥714.76m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.28 |
| Gross Margin | 75.43% |
| Net Profit Margin | 10.82% |
| Debt/Equity Ratio | 16.9% |
How did 2096 perform over the long term?
See historical performance and comparisonDividends
3.2%
Current Dividend Yield58%
Payout RatioDoes 2096 pay a reliable dividends?
See 2096 dividend history and benchmarks| Simcere Pharmaceutical Group dividend dates | |
|---|---|
| Ex Dividend Date | Jun 18 2024 |
| Dividend Pay Date | Jul 15 2024 |
| Days until Ex dividend | 47 days |
| Days until Dividend pay date | 74 days |
Does 2096 pay a reliable dividends?
See 2096 dividend history and benchmarks